Search Results - "Hazzan, M."

Refine Results
  1. 1

    Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort by Segaud, N., Legroux, I., Hazzan, M., Noel, C., Cortet, B.

    Published in Osteoporosis international (01-05-2018)
    “…Introduction In renal transplant patients, bone loss may be related to the drugs patients are taking but also to their past history of chronic kidney disease…”
    Get full text
    Journal Article
  2. 2

    Fibrosis Progression According to Epithelial‐Mesenchymal Transition Profile: A Randomized Trial of Everolimus Versus CsA by Rostaing, L., Hertig, A., Albano, L., Anglicheau, D., Durrbach, A., Vuiblet, V., Moulin, B., Merville, P., Hazzan, M., Lang, P., Touchard, G., Hurault deLigny, B., Quéré, S., Di Giambattista, F., Dubois, Y.‐C., Rondeau, E.

    Published in American journal of transplantation (01-05-2015)
    “…Markers of epithelial‐mesenchymal transition (EMT) may identify patients at high risk of graft fibrogenesis who could benefit from early calcineurin inhibitor…”
    Get full text
    Journal Article
  3. 3

    Daclizumab Versus Rabbit Antithymocyte Globulin in High‐Risk Renal Transplants: Five‐Year Follow‐up of a Randomized Study by Hellemans, R., Hazzan, M., Durand, D., Mourad, G., Lang, P., Kessler, M., Charpentier, B., Touchard, G., Berthoux, F., Merville, P., Ouali, N., Squifflet, J.‐P., Bayle, F., Wissing, K. M., Noël, C., Abramowicz, D.

    Published in American journal of transplantation (01-07-2015)
    “…We previously reported a randomized controlled trial in which 227 de novo deceased‐donor kidney transplant recipients were randomized to rabbit antithymocyte…”
    Get full text
    Journal Article Web Resource
  4. 4
  5. 5
  6. 6
  7. 7

    Anti‐viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy by Deltenre, P., Moreno, C., Tran, A., Ollivier, I., Provôt, F., Stanke, F., Lazrek, M., Castel, H., Canva, V., Louvet, A., Colin, M., Glowacki, F., Dharancy, S., Henrion, J., Hazzan, M., Noel, C., Mathurin, P.

    Published in Alimentary pharmacology & therapeutics (01-08-2011)
    “…Aliment Pharmacol Ther 2011; 34: 454–461 Summary Background  In end‐stage renal disease (ESRD) patients, hepatitis C virus (HCV) eradication improves patient…”
    Get full text
    Journal Article
  8. 8

    Subtotal parathyroidectomy with thymectomy for autonomous hyperparathyroidism after renal transplantation by Triponez, F., Dosseh, D., Hazzan, M., Noel, C., Vanhille, P., Proye, C. A. G.

    Published in British journal of surgery (01-10-2005)
    “…Background: There is currently no consensus on the operation that should be performed in patients with tertiary hyperparathyroidism (HPT) after renal…”
    Get full text
    Journal Article
  9. 9

    Long-Term Kinetics of a T-Lymphocytes Subset in Kidney Transplant Recipients: Relationship With Posttransplant Malignancies by Glowacki, F, Al Morabiti, M, Lionet, A, Labalette, M, Provot, F, Noel, C, Hazzan, M

    Published in Transplantation proceedings (01-10-2009)
    “…Abstract Immunosuppression is associated with a high incidence of malignancies among renal transplant patients. In this study, we investigated the relationship…”
    Get full text
    Journal Article Conference Proceeding
  10. 10
  11. 11
  12. 12

    Weaning from corticosteroid therapy after kidney transplantation by Hazzan, M, Glowacki, F, Lionet, A, Provôt, F, Noël, C

    Published in Néphrologie & thérapeutique (01-12-2009)
    “…For years, the numerous side effects of long term steroid administration have motivated their elimination from the immunosuppressive regimen in renal…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Selection of diabetic patients for islet transplantation. A single-center experience by Vantyghem, MC, Hazzan, M, Tourvieille, S, Provost, F, Perimenis, P, Declerck, N, Sergent, G, Kerr-Conte, J, Noel, C, Pattou, F

    Published in Diabetes & metabolism (01-11-2004)
    “…Since the Edmonton protocol, islet transplantation (IT) offers the prospect of adequate glycemic control with no major surgical risk. In our single-center…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Eligibility of diabetic patients receiving dialysis for islet after kidney transplantation by Vantyghem, M.C, Pattou, F, Girardot, C, Soudan, B, Hazzan, M, Noel, C

    Published in Transplantation proceedings (01-05-2004)
    “…The aim of this study was to assess the selection of candidates among 38 dialyzed diabetic patients referred between January 1, 1998 and December 31 2002 for…”
    Get full text
    Journal Article
  17. 17

    Strategies to increase the donor pool and access to kidney transplantation: an international perspective by Maggiore, Umberto, Oberbauer, Rainer, Pascual, Julio, Viklicky, Ondrej, Dudley, Chris, Budde, Klemens, Sorensen, Soren Schwartz, Hazzan, Marc, Klinger, Marian, Abramowicz, Daniel

    Published in Nephrology, dialysis, transplantation (01-02-2015)
    “…In this position article, DESCARTES (Developing Education Science and Care for Renal Transplantation in European States) board members describe the current…”
    Get full text
    Journal Article
  18. 18

    Pentoxifylline prevents upregulation of monocyte tissue factor in renal transplant recipients undergoing post-graft complications by Susen, S, Hazzan, M, Labalette, M, Zawadzki, C, Dessaint, J P, Lelièvre, G, Jude, B, Noël, C

    Published in Thrombosis and haemostasis (01-11-2000)
    “…Pentoxifylline (PTX) has been demonstrated to improve graft survival in renal transplant recipients undergoing post graft complications. As activated monocytes…”
    Get more information
    Journal Article
  19. 19
  20. 20